The Ebola outbreak in the Democratic Republic of the Congo has now surpassed 4,000 confirmed cases, becoming the largest such epidemic ever recorded in the country. Health authorities reported 4,053 cases and 1,850 deaths as of Thursday, with a case fatality rate of around 46 percent. The Bundibugyo strain behind the surge has no proven vaccine or targeted therapy, and insecurity in the east continues to slow the response.
KINSHASA, Aug. 8 — The Ebola outbreak in the Democratic Republic of the Congo has now passed the 4,000-case threshold, the country’s health authority said Thursday, confirming that the epidemic has become the largest in the country’s recorded history and one of the worst Ebola events anywhere in the past decade.
Health officials reported 4,053 confirmed cases and 1,850 deaths as of Thursday, a case fatality rate of approximately 46 percent. The outbreak, declared on May 15, is concentrated in the mineral-rich eastern provinces of Ituri, North Kivu, Haut-Uele, Tshopo and South Kivu. Ituri alone accounts for more than 87 percent of all confirmed infections.
The pathogen driving the surge is the Bundibugyo ebolavirus, a strain first identified in western Uganda in 2007. Unlike the better-known Zaire strain, for which an effective vaccine exists, no product has yet been proven safe and effective against Bundibugyo. The lack of a licensed tool means frontline health workers are intervening with the same basic measures used during the 2018-2020 North Kivu outbreak: isolation, contact tracing, safe burials and supportive care.
Several experimental candidates are in the pipeline. A vaccine developed by the University of Oxford and the Serum Institute of India entered Phase 1 clinical trials in Britain in late July, and a separate candidate from Moderna is expected to begin Phase 1 testing in Canada this week. The PARTNERS treatment trial is now operating at three sites in Ituri and has enrolled more than 50 patients, while a trial of the oral antiviral obeldesivir is testing whether post-exposure prophylaxis can prevent infections among close contacts.
The World Health Organization, which in May declared the outbreak a public health emergency of international concern (PHEIC), warned this week that the epidemic is still expanding beyond the capacity of the response. Surveillance data show that 30 of 44 deaths recorded on Monday occurred outside treatment centers, a signal that many infected people are dying at home without ever being registered. Contact tracing coverage has fallen to about 78 percent, well below the 95 percent threshold needed to reliably interrupt transmission chains.
The medical charity Médecins Sans Frontières (MSF) described the situation in eastern DRC as the most critical phase of any Ebola response it has mounted. Population movements linked to artisanal mining, cross-border trade and continuing armed violence in North Kivu and Ituri have repeatedly broken quarantine lines. The WHO has assessed the risk of further spread to Uganda, Rwanda, South Sudan and Burundi as high, though Uganda officially declared its own Bundibugyo outbreak over late last month after 42 days without a new locally transmitted case.
The economic and social impact is also widening. Schools in parts of Ituri have suspended classes, mining cooperatives have reduced operations, and the cross-border trade that sustains towns like Bunia and Beni has slowed. Africa Centres for Disease Control and Prevention (Africa CDC) Director-General Jean Kaseya travelled to Bunia this week to assess the response, calling for a substantial expansion of treatment beds, burial teams, community health workers and laboratory capacity.
International donors have so far committed around $80 million to the response, but the WHO and African Union both warn that funding remains well short of what is needed to bring transmission under control. The DRC’s public health authority has called for a continental emergency stockpile of Bundibugyo-specific therapeutics, arguing that the global response model built around the Zaire strain has left a critical gap in the continent’s defenses.
The next several weeks are expected to be decisive. The rainy season in eastern DRC begins in September, which will both complicate logistics and increase the mobility of rural communities — a combination that public health specialists say could push the outbreak into a new phase of geographic spread. Until a working vaccine or therapeutic becomes available, the response will continue to lean on the same fragile foundation of contact tracing, safe burials and frontline clinical care that has, so far, been unable to outpace the virus.